IDEXX > Livestock/Poultry Testing > Newsletter > July 2004 Edition
 

Animal Health Updates

 

samples

Subscribe now to receive this e-newsletter.
 

THE LATEST NEWS

Monitoring vaccinated populations for serology interpretation and results analysis (sampling and sample size)

Introduction
Serology is an important tool in monitoring vaccines and maternal antibodies, establishing proper vaccination timing, detecting infection, and determining disease prevalence. To maximize the benefits of this monitoring tool, companies should make it part of a comprehensive preventive medicine program.

Well-defined objectives and the correct interpretation of data are necessary to obtain the real benefits of serology. In addition to knowing the test specifications (i.e., sensitivity, specificity, predictive value) and the historical data of the population, a monitoring program should be established.

A monitoring program depends on sample size and frequency of sampling. One of the main concerns in the field is the amount of samples to be collected. The determination of the minimum amount of samples is vital for the validity of the results.

Due to its statistical value, a 30-sample size is widely used in veterinary medicine as well as in other areas. This sample size was extensively used in monitoring programs until the pressure for decreasing costs started to be a priority for companies. As a consequence, the number of serological samples collected was reduced. The key questions are:

  • How much information is lost?

  • What are the risks when the number of samples is decreased?

In this brief discussion, we will attempt to unify the basic concepts of sampling, show why the 30-sample size is recommended, and determine what the implications are when working with various samples sizes.

Sampling Concepts
A sample is any part of a population, whereas sampling is the process of collecting samples from a population.1

The idea behind utilizing sampling in diagnostic tests is that the collection of relative data of some elements of the population, and the corresponding analysis thereof, should provide relevant information applicable to the whole population. Sampling is closely related to the basis of the process by which antibodies or antigens are investigated by scrutiny; investigation of just one part of the population to make inferences for the whole, instead of dealing with the whole, in which case it would be a census.

Sampling is based on two premises. First, the similarity among the elements of the population is such that a certain number of them will properly represent the characteristics of the whole population. Second, the discrepancies between the values of the population variables (parameters) and the values of the same variables obtained from the sample (statistic) are minimized because some of the measurements underestimate the value of the parameter while others overestimate it. If the sample has been properly obtained (representative samples), the variations in those values tend to counterbalance and cancel one another, resulting in sample measurements that are, in general, close to the one of the population.3

Characteristics of a Good Sample
The essence of a good sample lies in establishing a means to infer, as precisely as possible, the characteristics of a population through measurement of the characteristics of the sample. A good sample comprises:

  1. Precision: The agreement of the results obtained from the sample (statistic) and the corresponding results that would be measured in the whole population (parameters). Precision is the measurement of the sampling error; the smaller the sampling error, the higher the precision of the sample.2

  2. Efficiency: The comparative measurement between different sampling projects. It is said that a given project is more efficient than others in specific conditions if it gives more reliable and economic results with the same precision, or higher precision with the same cost. It is important for a sample to be precise and efficient (Figure 1).2

  3. Accuracy: The degree of absence of nonsampling errors in the sample. A sample is considered accurate if the overestimate and underestimate measurements compensate each other among the components of the sample.2

Figure 1.

possible combinations of percision and accuracy

Steps for Selecting Samples:

    Step 1 : Definition of the population of interest
    Step 2 : Determination of sample size
    Step 3 : Determination of specific procedure for sample selection
    Step 4 : Collection of sample based on the above steps

Types of Sampling
There are a wide variety of sampling types, but a distinction should be made between probability sampling and nonprobability sampling.

Probability Sampling: Each element of the population has a known (nonzero) chance of being selected to be part of the sample. This is also known as random sampling.

Nonprobability Sampling: The selection of the elements to be included in the sample is dependent upon the investigator's judgment.

It is important to notice that in any population there are many possible samples of any size. What should be kept in mind is that classical statistical inference is based on what happens when different samples of the same size are repeatedly selected in the same population.

Consider the analysis of three samplings of five samples each (n=5) from a known population, and calculation of their means. The means will be close, yet different. It can be imagined that there are three different parameters in the population; however, the statistical theory recommends not stopping at three samplings, but to keep taking samples until certain mean values are repeated with more frequency. Then it will be apparent that sample means closer to the population mean will be repeated more frequently than the more distant ones. When those values are plotted on a two-axis system, a Gaussian curve (normal curve) will be observed. This distribution of the sample means is known as the sampling distribution of the means, or sampling distribution.1,2

Symmetrically positioned intervals centered on the most likely mean are called confidence intervals of the mean. Three intervals are commonly referenced. The first is 68%, the second 95% and the third 99%. Figure 2 illustrates the Gaussian curve and the respective confidence intervals.

Figure 2. Area under the normal curve for 1, 2 and 3 standard deviations from the mean.2

graph

To understand the meaning of these intervals, consider the 68% confidence interval. It is clear that the sampling distribution mean is equal to the mean of the population, and that in practice, of all the possible samples of size n, only one is taken and its mean is used as an estimator of the population mean (which is unknown). Notice that the sampling mean may or may not be within the calculated confidence interval, 68% in this case. To be in the 68% level of confidence interval does not mean that there are 68 chances out of a 100 for the sampling mean to be included in such interval; instead, it means that if 100 different random samples were taken from the population, and the 68% confidence interval constructed for each, the population mean is expected to fall within 68 of these intervals.

Sample Size and Data Precision
For same size samples, the higher the confidence level, the higher the precision. Precision also increases as the number of elements in the sample increases, but the increase in sample number is not proportional to data precision.1,2

There are tables that can be used that include three components for errors in the range of 1% to 10%, and for confidence levels of 68%, 95% and 99.7% (Table 1).

Table 1: Correlation of error, confidence level and number of elements for a sample of infinite dichotomous populations (n>3000).2


Error(e) n=PQ/e2 68% n=4PQ/e2 95% n=9PQ/e2 99%
P=Q=0.50
0.01 2500 10000 22500
0.02 625 2500 5625
0.03 278 1112 2502
0.04 156 624 1404
0.05 100 400 900
0.06 70 280 630
0.07 51 204 459
0.08 39 156 351
0.09 31 124 279
0.10 25 100 225

P=Possibility that this disease will occur
Q=Possibility that this disease will not occur
e=error
n=number of samples

This is a general table that can be used on calculations for samples from studies of diverse natures. According to the table, for an infinite population with 9% error and a confidence level of 68%, 31 samples should be taken in a probability sampling to determine the presence of a particular disease and/or vaccine immune response situation in at least 68% of the population.

Sampling Strategy According to the Objective of the Study
Regarding the serology objective as related to the sampling type, two situations may be considered: disease detection and disease prevalence determination. We will focus on disease detection in vaccinated animals, a common study at private laboratory level.5

The formula to calculate sample size, considering disease prevalence in an infinite population (>3000) is:

n = log (error) ÷ log (1- disease prevalence)

Example: What would be the sampling strategy to detect a determined disease in a population with 10% prevalence and 95% confidence?

n = log0.05 ÷ log (1-0.10)

Answer: n = 29

This means that if we take a minimum of 29 animals, we will have the chance to detect at least one infected animal, with a confidence level of 95%. Table 2 illustrates the sample size necessary to detect disease given various levels of confidence and prevalence.

Table 2. Estimated sample sizes to detect disease in populations with a large number of individuals (2000).2


Confidence Percent Prevalence (%)
  5% 10% 15%
99% 90 44 28
95% 58 28 18
90% 45 22 14
85% 37 18 12
80% 31 15 10
75% 27 13 9

The number of samples needed to ensure 95% confidence for disease detection (that is 95% probability of disease detection), considering a population with an infection rate of 10%, is 28. The difference between 28 and 29 samples can be accounted for by the table's basis on a population of 2000 individuals and the calculation having been done on a population equal to or greater than 3000 individuals (infinite).

From Table 2 it can be seen that when the number of samples decreases, you have to work either with a lower percentage of confidence or wait until the disease increases in prevalence to be detected. In preventive medicine, the objective is to detect disease as early as possible, with the highest index of confidence. This is why, when working with 95% confidence to detect an infection with 10% prevalence, the recommended sample size is 28.

In the field, sampling frequency is a common justification for using a small sample size. Caution is well advised in this case, since error is not corrected by taking repeated small number of samples. For example, suppose that a company has elected to use a sample size of 10, instead of 29 in the hope of detecting 15% prevalence in a herd of size 2000. From Table 2 above, this decision reduces their confidence from 99% to 80%. If 13 samples are taken from each house every five weeks, it will result in 75% confidence to detect 10% prevalence.

Another way to understand the consequences of decreasing the sample size is revealed in the following table. Table 3 shows the number of samples needed, according to the herd size, to detect infection in at least one animal (n=1), in a population with 5% prevalence and 95% confidence. Compare the confidence percentage, when the number of samples is reduced to 10.

Table 3. Number of samples, according to population size, to detect infection with 95% confidence in a population with 5% of disease prevalence, and degree of detection confidence when the number of samples is reduced to 10.4


Population
Size
Suggested
Number of
Samples
Confidence Reduced
Number of
Samples
Reduced
Confidence

20 19 95% 10 50%
40 31 95% 10 44%
60 38 95% 10 43%
80 42 95% 10 42%
100 45 95% 10 42%
120 47 95% 10 41%
160 49 95% 10 41%
200 51 95% 10 41%
300 54 95% 10 40%
400 55 95% 10 40%
500 56 95% 10 40%
1000 57 95% 10 40%
2000 58 95% 10 40%
>=3000 59 95% 10 40%

With only 10 samples per population, the probability of detecting any infection decreases to 40% (assuming 5% prevalence).

Table 4. Number of samples to have 95% probability to detect one (1) or more positives in an infected population.2


Population
Size
Percent Prevalence (%)

  50 40 30 25 20 15 10 5 2 1 0.5 0.1
20 4 6 7 9 10 12 16 19 20 20 20 20
30 4 6 8 9 11 14 19 26 30 30 30 30
40 5 6 8 10 12 15 21 31 40 40 40 40
50 5 6 8 10 12 16 22 35 46 50 50 50
60 5 6 8 10 12 16 23 38 55 60 60 60
70 5 6 8 10 13 17 24 40 62 70 70 70
80 5 6 8 10 13 17 24 42 68 79 80 80
90 5 6 8 10 13 17 25 43 73 87 90 90
100 5 6 9 10 13 17 25 45 78 96 100 100
150 5 6 9 11 13 18 27 49 95 130 148 150
200 5 6 9 11 13 18 27 51 105 155 190 200
500 5 6 9 11 14 19 28 56 129 225 349 500
1000 5 6 9 11 14 19 29 57 138 258 450 950
5000 5 6 9 11 14 19 29 59 147 290 564 2253
10000 5 6 9 11 14 19 29 59 148 294 581 2588
5 6 9 11 14 19 29 59 149 299 596 2995

Conclusion
The basic concepts of sampling should be known before establishing a monitoring program. Statistical tables should always be consulted before changing sample sizes. When a company decides to reduce costs, it should also recognize that lowering the number of samples could lead to a loss of information and a potential misinterpretation of results, which actually can lead to a higher cost of production.

The advantage of serology, mainly ELISA, is early disease detection. The use of 23 samples (between 29 and 19) for vaccinated animals, resulting in a 95% confidence (or probability) in detecting diseases with 10–15% prevalence is strongly recommended. The number of samples for detection of diseases of slow transmission and low prevalence (<5%) can be taken from Table 4.

 

References

1.

Bhattacharya GK, et al. Statistical Concepts and Methods. New York: John Wiley & Sons. 1977.

2.

Martin SW, Meek AH, Willeberg P. Veterinary epidemiology—principles and methods. Ames, IA:Iowa State University Press.

3.

Mattar NF. Pesquisa de Marketing. Amostragem, confiança e numero de elementos da amostra. Editora Atlas Sao Paulo, 2001.

4.

Ridpath HD. Personal comunication, 1994.

5.

Snelson H. Serology as an aid to disease diagnosis and vaccine management. Technical Services Update, Schering-Plough Animal Health. 2003.


Back to the Top

THE LATEST NEWS

 Case Report
 

Our sincere thanks to Dr. Michael Collins for providing us with this case report.

 

The story of a Jersey cow, Dolly, that was detected positive for Johne´s disease

farm


Dolly is a Jersey cow. Her story began on a traditional family farm in a midwestern state in the U.S. She was born on this farm September 8, 1999 and was raised with loving care to join the herd of milking cows that provide the primary source of income for the farm family with three young children.
calf

In January of 2001, when Dolly was a yearling heifer about 16 months old, she was bred by artificial insemination to a good Jersey bull so that her daughters would carry the best possible genetics to make them excellent milk producers. Nine months later, on October 22, 2001, Dolly had her first calf and started her first lactation.

Milk production in dairy cows is measured monthly and then reported as total milk production for each lactation. To fairly compare cows for milk production, milk production data is converted to a standardized performance parameter called mature equivalent for a 305-day lactation, abbreviated ME305. In the U.S., the ME305 is reported in pounds of milk, while in other countries kilograms are used. To be fair, ME305 values for first-lactation cows are reported separately from ME305 values for more mature cows (second or higher lactation) since milk production during the first lactation is not as high as that of more mature cows.

Breed also affects the ME305. The ME305 of Jersey cows is less than that of comparable-age Holstein cows. However, although Jersey cows produce less total milk than Holstein cows, the fat and protein content of Jersey cow milk is higher; so, pound for pound, a higher price is paid for Jersey cow milk than for Holstein cow milk.

Dolly's first lactation was an excellent one. She produced 9.4% more milk than did her herdmates of the same age. Specifically, her first lactation ME305 was 16,948 lb while the 1st lactation ME305 for all other first lactation cows in the herd was 15,498 lb.

The production cycle of a dairy cow is roughly 12 months. The cycle starts when she delivers a calf and starts producing milk. She continues producing milk for roughly 10 months and then gets a two month rest, without being milked, before the next calf is born and the next lactation begins. Since the gestation period for a cow is the same as for a human, nine months, the cow must be bred and become pregnant again just two months after having a calf in order for her to be ready to deliver the next calf and start the next lactation nine months later. That was Dolly's situation in September of 2002—she had finished her first lactation and was eight months pregnant, ready to have her second calf and start her second lactation.

But Dolly's life story was affected by Johne's disease, a chronic, debilitating enteritis of ruminants caused by infection with Mycobacterium paratuberculosis. Dolly's mother had Johne's disease, as did several other cows in this Jersey herd. In fact, the estimated infection rate was roughly 40%. As part of the Johne's control program, the herd owners were testing every cow in the herd as they approached the end of their lactation in an effort to identify those cows that were infected with M. paratuberculosis and most likely to transmit the infection to their own calves or others in the herd fed their colostrum or milk.

Dolly

Dolly, taken in September, 2002, looked perfectly healthy.

When Dolly was tested for M. paratuberculosis at the end of her first lactation, her ELISA S/P was 1.09, a strong positive. High ELISA S/P values, over 1.0, in known M. paratuberculosis-infected herds indicates a very high probability of infection. Additionally, strong positive ELISA results indicate that:

  • the infection has become generalized in the cow
  • probable infection of the fetus in utero
  • probable excretion of M. paratuberculosis in the colostrum and milk when the cow next calves
  • high levels of M. paratuberculosis shedding in manure
  • a cow that will very likely break with clinical Johne's disease shortly after the start of the next lactation
In short, Dolly was a major source of infection for calves on the farm and would not be a profit-making cow on the next lactation. She needed to be culled from the herd. This was a difficult fact to face for the herd owners.


The owners were committed to follow the Johne's disease control program laid out by the University of Wisconsin School of Veterinary Medicine (UW-SVM) and agreed that Dolly would be culled. To verify that the culling recommendation was sound and to gain more knowledge about Johne's disease in general, Dolly was taken to the UW-SVM to be necropsied. The necropsy showed classical gross pathology of Johne's disease: an obviously thickened ileum (Figure 1). When mucosa from that ileum was crushed on a glass slide and stained with an acid-fast stain, typical large clumps of acid-fast bacteria were readily seen (Figure 2). Subsequently, histopathology on multiple gut and lymph node tissues confirmed the Johne's disease diagnosis, and M. paratuberculosis (M.pt.) was isolated from those same tissues as well as fecal samples collected from Dolly at the necropsy.
Figure 1
abnormal nicropsy
Figure 2

Dolly's story is an example of how regular use of the M.pt. ELISA can identify cows that are the major sources of infection for the herd and help owners get those cows out of the herd or managed in a way that will limit the risk of infection spread. This herd had six cows that tested strong-positive on the IDEXX M.pt. ELISA. When fecal samples were cultured from these cows, five of the six were found to be "heavy shedders," excreting M.pt. in every gram of feces (cows typically generate 35,000 grams of feces every day). The other cow was shedding M.pt. at a lower rate.

ELISA S/P values are directly correlated with the rate of M.pt. shedding in feces. Therefore, the magnitude of the ELISA S/P should be used when making management decisions on cows in M.pt.-infected herds: cows with the highest S/P should be culled first.

Changes in herd management remain the single most important method of controlling Johne's disease. Fast affordable diagnostic testing by M.pt. ELISA, coupled to a systematic plan of action for using the test results, will accelerate Johne's disease control.

For more information about Johne's disease visit the Johne's Information Center Web site.

For more information on IDEXX diagnostics for detection of infection with Mycobacterium paratuberculosis, the causative agent of Johne´s disease, visit our M.pt. test kit Web page.

The recommendations in the case report in this edition of the IDEXX Animal Health Updates were provided by Dr. Mike Collins. The information and opinions cited in Dolly's case are an individual example based on Dr. Collins' experience and are not necessarily indicative of all Johne´s cases.

Case Report prepared by:
Michael T. Collins, DVM, PhD, Professor of Microbiology
University of Wisconsin, School of Veterinary Medicine


 

TECHNICAL TIP

Back to the Top

Tracking kit lot number and expiration date information in xChek*

As part of a good comprehensive quality control program, it is recommended that customers track the kit lot number and expiration date for each ELISA test kit that they are running. xChek provides a convenient way to track this information. Kit lot numbers and expiration dates can be entered in two places in the xChek software. This information can be entered each time an assay is run or if you will be running the same lot number for some time, it can be entered into the database assay information. Lot number information can be entered in Plate View after reading your plate, by double-clicking the kit or expiration date field. Entering the information this way will apply it only to this data set. By choosing Database> Assays and selecting the specific test, you can also enter the kit lot and expiration date information. This information will be applied to all testing until a new lot and expiration date are added.


 

LEARN MORE

Back to the Top

To learn more about our products and services, innovative technologies, trusted service and support, and our global offices, visit our Web site.


 

VISIT US AT THE FOLLOWING EVENTS

Back to the Top

San Francisco, CA USA—July 8–10, 2004
NPIP

Quebec, Canada—July 11–16, 2004
23rd World Buiatrics Congress

Philadelphia, PA USA—July 24–28, 2004
AVMA and AAAP

Athens, GA USA—August 5–7, 2004
AVM

San Pedro Sula, Honduras—August 25–27, 2004
XVII Central American Poultry Congress


 
 

WE WANT TO HEAR FROM YOU

Back to the Top

...and we want you to hear from us! Pass the following link along to your friends and colleagues. They can register for Animal Health Updates to stay informed of the latest IDEXX products and services and respond to various customer and market surveys that we will soon offer. Registration is easy at www.idexx.com/production/livestockpoultrynews.

 

Questions or comments?

 
* xChek is a trademark or a registered trademark of IDEXX Laboratories, Inc. in the United States and/or other countries. All other product and company names are trademarks or registered trademarks of their respective holders.
 

This symbol indicates PDF-formatted materials. To view, you may need to download a free copy of Adobe® Reader® software.

 
© 2008 IDEXX Laboratories, Inc.
All rights reserved.